Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00315068 |
Date of registration:
|
13/04/2006 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation
|
Scientific title:
|
The Value of Amino-Terminal Brain Natriuretic Peptide and C-Reactive Protein Serum Levels for Predicting Recurrence of Atrial Fibrillation and/or Atrial Flutter After Radiofrequency Catheter Ablation |
Date of first enrolment:
|
April 2004 |
Target sample size:
|
180 |
Recruitment status: |
Active, not recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT00315068 |
Study type:
|
Observational |
Study design:
|
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Switzerland
| | | | | | | |
Contacts
|
Name:
|
Pierre-Frederic Keller, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Cardiology Division University Hospital |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- atrial fibrillation
- indication for catheter ablation of atrial fibrillation
Exclusion Criteria:
- significant valvulopathy
- previous catheter ablation for atrial fibrillation or atrial flutter
- left ventricular ejection fraction < 30%
- Severe heart failure (NYHA IV)
- Severe enlargement of left atrium (> 55mm)
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Atrial Fibrillation
|
Secondary ID(s)
|
PRD-03-I-03
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|